Literature DB >> 11029085

Transjugular retrograde obliteration for chronic portosystemic encephalopathy.

F Chikamori1, N Kuniyoshi, S Shibuya, Y Takase.   

Abstract

Chronic portosystemic encephalopathy (CPSE) is uncommon, and its management has yet to be determined. We have been able to control five cases of CPSE using transjugular retrograde obliteration (TJO), and we report our clinical results with this technique. All of the five patients were suffering from cirrhosis and had gastric varices and large gastrorenal shunts. According to Sherlock's classification, the grade of encephalopathy was II in two patients, III in two, and IV in one. According to Child's classification, one had class B and four had class C cirrhosis. TJO was performed using a 6-F angiographic catheter with an occlusive balloon 20 mm in diameter. Absolute ethanol and 5% ethanolamine oleate with iopamidol were used to obliterate the gastrorenal shunt. The gastrorenal shunt was successfully obliterated, and the encephalopathy improved to grade 0 after TJO in all cases. The portal flow volume increased significantly from 542 +/- 189 to 992 +/- 139 mL/min (p < 0.01). The plasma ammonia levels before and after TJO were 189 +/- 40 and 51 +/- 23 microg/dL, and the indocyanine green retention rates at 15 min were 44 +/- 13% and 27 +/- 12%, with both changes being significant (p < 0.01). Minor complications observed were fever of over 38 degrees C and tarry stools due to hemorrhagic gastritis in one patient, which was being controlled conservatively. One patient died of hepatocellular carcinoma 27 months after TJO. The other four patients survived without recurrence of CPSE 17-74 months (44 +/- 24 months) after TJO. We conclude that TJO can be adopted as a safe and effective treatment for CPSE.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11029085     DOI: 10.1007/s002610000046

Source DB:  PubMed          Journal:  Abdom Imaging        ISSN: 0942-8925


  11 in total

1.  Laparoscopic division of a portosystemic shunt to treat chronic hepatic encephalopathy.

Authors:  Marie Seman; Olivier Scatton; Stephane Zalinski; Ariane Chrissostalis; Paul Legmann; Olivier Soubrane
Journal:  HPB (Oxford)       Date:  2008       Impact factor: 3.647

2.  Transjugular Intrahepatic Portosystemic Shunt (TIPS) versus Balloon-occluded Retrograde Transvenous Obliteration (BRTO) for the Management of Gastric Varices.

Authors:  Wael E A Saad; Michael D Darcy
Journal:  Semin Intervent Radiol       Date:  2011-09       Impact factor: 1.513

3.  The History and Evolution of Balloon-occluded Retrograde Transvenous Obliteration (BRTO): From the United States to Japan and Back.

Authors:  Wael E A Saad
Journal:  Semin Intervent Radiol       Date:  2011-09       Impact factor: 1.513

4.  Variations of Balloon-occluded Retrograde Transvenous Obliteration (BRTO): Balloon-occluded Antegrade Transvenous Obliteration (BATO) and Alternative/Adjunctive Routes for BRTO.

Authors:  Wael E A Saad; Daniel Y Sze
Journal:  Semin Intervent Radiol       Date:  2011-09       Impact factor: 1.513

5.  Shunt occlusion for portosystemic shunt syndrome related refractory hepatic encephalopathy-A single-center experience in 21 patients from Kerala.

Authors:  Cyriac Abby Philips; Lijesh Kumar; Philip Augustine
Journal:  Indian J Gastroenterol       Date:  2017-11-10

Review 6.  Nonendoscopic management strategies for acute esophagogastric variceal bleeding.

Authors:  Sanjaya K Satapathy; Arun J Sanyal
Journal:  Gastroenterol Clin North Am       Date:  2014-09-27       Impact factor: 3.806

7.  Percutaneous transhepatic obliteration and percutaneous transhepatic sclerotherapy for intractable hepatic encephalopathy and gastric varices improves the hepatic function reserve.

Authors:  Toru Ishikawa; Michitaka Imai; Masayoshi Ko; Hiroki Sato; Yujiro Nozawa; Tomoe Sano; Akito Iwanaga; Keiichi Seki; Terasu Honma; Toshiaki Yoshida
Journal:  Biomed Rep       Date:  2016-11-16

8.  Balloon-occluded retrograde transvenous obliteration of gastric varices: concept, basic techniques, and outcomes.

Authors:  Wael E A Saad
Journal:  Semin Intervent Radiol       Date:  2012-06       Impact factor: 1.513

9.  Balloon-occluded Retrograde Transvenous Obliteration (BRTO): Technical Results and Outcomes.

Authors:  Wael E A Saad; Saher S Sabri
Journal:  Semin Intervent Radiol       Date:  2011-09       Impact factor: 1.513

10.  The short-term effects of balloon-occluded retrograde transvenous obliteration, for treating gastric variceal bleeding, on portal hypertensive changes: a CT evaluation.

Authors:  Sung Ki Cho; Sung Wook Shin; Eun Young Yoo; Young Soo Do; Kwang Bo Park; Sung Wook Choo; Heon Han; In Wook Choo
Journal:  Korean J Radiol       Date:  2007 Nov-Dec       Impact factor: 3.500

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.